Combinatorial gene therapy renders increased survival in cirrhotic rats

<p>Abstract</p> <p>Background</p> <p>Liver fibrosis ranks as the second cause of death in México's productive-age population. This pathology is characterized by acummulation of fibrillar proteins in hepatic parenchyma causing synthetic and metabolic disfunction. Re...

Full description

Bibliographic Details
Main Authors: Armendáriz-Borunda Juan S, Muñoz-Valle Jose F, Senties-Gomez María D, Segura-Flores Aida A, Gálvez-Gastélum Francisco J
Format: Article
Language:English
Published: BMC 2010-05-01
Series:Journal of Biomedical Science
Online Access:http://www.jbiomedsci.com/content/17/1/42
_version_ 1818787565628555264
author Armendáriz-Borunda Juan S
Muñoz-Valle Jose F
Senties-Gomez María D
Segura-Flores Aida A
Gálvez-Gastélum Francisco J
author_facet Armendáriz-Borunda Juan S
Muñoz-Valle Jose F
Senties-Gomez María D
Segura-Flores Aida A
Gálvez-Gastélum Francisco J
author_sort Armendáriz-Borunda Juan S
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Liver fibrosis ranks as the second cause of death in México's productive-age population. This pathology is characterized by acummulation of fibrillar proteins in hepatic parenchyma causing synthetic and metabolic disfunction. Remotion of excessive fibrous proteins might result in benefit for subjects increasing survival index. The goal of this work was to find whether the already known therapeutical effect of human urokinase Plasminogen Activator and human Matrix Metalloprotease 8 extends survival index in cirrhotic animals.</p> <p>Methods</p> <p>Wistar rats (80 g) underwent chronic intoxication with CCl<sub>4</sub>: mineral oil for 8 weeks. Cirrhotic animals were injected with a combined dose of Ad-delta-huPA plus Ad-MMP8 (3 × 10<sup>11 </sup>and 1.5 × 10<sup>11 </sup>vp/Kg, respectively) or with Ad-beta-Gal (4.5 × 10<sup>11</sup>) and were killed after 2, 4, 6, 8 and 10 days. Then, liver and serum were collected. An additional set of cirrhotic animals injected with combined gene therapy was also monitored for their probability of survival.</p> <p>Results</p> <p>Only the cirrhotic animals treated with therapeutical genes (Ad-delta-huPA+Ad-MMP-8) showed improvement in liver fibrosis. These results correlated with hydroxyproline determinations. A significant decrement in alpha-SMA and TGF-beta1 gene expression was also observed. Cirrhotic rats treated with Ad-delta-huPA plus Ad-MMP8 had a higher probability of survival at 60 days with respect to Ad-beta-Gal-injected animals.</p> <p>Conclusion</p> <p>A single administration of Ad-delta-huPA plus Ad-MMP-8 is efficient to induce fibrosis regression and increase survival in experimental liver fibrosis.</p>
first_indexed 2024-12-18T14:09:48Z
format Article
id doaj.art-445c2f39194b431ea22e3045d3f4f42f
institution Directory Open Access Journal
issn 1021-7770
1423-0127
language English
last_indexed 2024-12-18T14:09:48Z
publishDate 2010-05-01
publisher BMC
record_format Article
series Journal of Biomedical Science
spelling doaj.art-445c2f39194b431ea22e3045d3f4f42f2022-12-21T21:05:09ZengBMCJournal of Biomedical Science1021-77701423-01272010-05-011714210.1186/1423-0127-17-42Combinatorial gene therapy renders increased survival in cirrhotic ratsArmendáriz-Borunda Juan SMuñoz-Valle Jose FSenties-Gomez María DSegura-Flores Aida AGálvez-Gastélum Francisco J<p>Abstract</p> <p>Background</p> <p>Liver fibrosis ranks as the second cause of death in México's productive-age population. This pathology is characterized by acummulation of fibrillar proteins in hepatic parenchyma causing synthetic and metabolic disfunction. Remotion of excessive fibrous proteins might result in benefit for subjects increasing survival index. The goal of this work was to find whether the already known therapeutical effect of human urokinase Plasminogen Activator and human Matrix Metalloprotease 8 extends survival index in cirrhotic animals.</p> <p>Methods</p> <p>Wistar rats (80 g) underwent chronic intoxication with CCl<sub>4</sub>: mineral oil for 8 weeks. Cirrhotic animals were injected with a combined dose of Ad-delta-huPA plus Ad-MMP8 (3 × 10<sup>11 </sup>and 1.5 × 10<sup>11 </sup>vp/Kg, respectively) or with Ad-beta-Gal (4.5 × 10<sup>11</sup>) and were killed after 2, 4, 6, 8 and 10 days. Then, liver and serum were collected. An additional set of cirrhotic animals injected with combined gene therapy was also monitored for their probability of survival.</p> <p>Results</p> <p>Only the cirrhotic animals treated with therapeutical genes (Ad-delta-huPA+Ad-MMP-8) showed improvement in liver fibrosis. These results correlated with hydroxyproline determinations. A significant decrement in alpha-SMA and TGF-beta1 gene expression was also observed. Cirrhotic rats treated with Ad-delta-huPA plus Ad-MMP8 had a higher probability of survival at 60 days with respect to Ad-beta-Gal-injected animals.</p> <p>Conclusion</p> <p>A single administration of Ad-delta-huPA plus Ad-MMP-8 is efficient to induce fibrosis regression and increase survival in experimental liver fibrosis.</p>http://www.jbiomedsci.com/content/17/1/42
spellingShingle Armendáriz-Borunda Juan S
Muñoz-Valle Jose F
Senties-Gomez María D
Segura-Flores Aida A
Gálvez-Gastélum Francisco J
Combinatorial gene therapy renders increased survival in cirrhotic rats
Journal of Biomedical Science
title Combinatorial gene therapy renders increased survival in cirrhotic rats
title_full Combinatorial gene therapy renders increased survival in cirrhotic rats
title_fullStr Combinatorial gene therapy renders increased survival in cirrhotic rats
title_full_unstemmed Combinatorial gene therapy renders increased survival in cirrhotic rats
title_short Combinatorial gene therapy renders increased survival in cirrhotic rats
title_sort combinatorial gene therapy renders increased survival in cirrhotic rats
url http://www.jbiomedsci.com/content/17/1/42
work_keys_str_mv AT armendarizborundajuans combinatorialgenetherapyrendersincreasedsurvivalincirrhoticrats
AT munozvallejosef combinatorialgenetherapyrendersincreasedsurvivalincirrhoticrats
AT sentiesgomezmariad combinatorialgenetherapyrendersincreasedsurvivalincirrhoticrats
AT segurafloresaidaa combinatorialgenetherapyrendersincreasedsurvivalincirrhoticrats
AT galvezgastelumfranciscoj combinatorialgenetherapyrendersincreasedsurvivalincirrhoticrats